SCHEMBL5086104

SCHEMBL5086104

c1ccc(-c2ccc3ccc(Nc4nccn5c(C6CC(CN7CCC7)C6)ncc45)cc3n2)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 8/20 0.48
CYP3A4 P08684 4/20 0.48
INSR P06213 2/20 0.48
EGFR P00533 1/20 0.48
KDR P35968 1/20 0.48
SYK P43405 10/20 0.38
TNK2 Q07912 1/20 0.36
ROCK2 O75116 1/20 0.35
PRKD3 O94806 1/20 0.35
LYN P07948 1/20 0.35
RET P07949 1/20 0.35
FGFR1 P11362 1/20 0.35
RPS6KB1 P23443 1/20 0.35
FLT4 P35916 1/20 0.35
FLT3 P36888 1/20 0.35
FRK P42685 1/20 0.35
STK3 Q13188 1/20 0.35
ROCK1 Q13464 1/20 0.35
PTK6 Q13882 1/20 0.35
ERBB4 Q15303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5083358 0.91 IGF1R (0.58) IGF1RCYP3A4INSREGFRKDR
SCHEMBL5078929 0.83 IGF1R (0.35) IGF1RCYP3A4INSREGFRKDR
SCHEMBL5086596 0.77 TNK2 (0.42) IGF1RCYP3A4INSREGFRKDR
SCHEMBL5081269 0.77 CYP3A4 (0.39) IGF1RCYP3A4SYKTNK2
SCHEMBL5086159 0.76 TNK2 (0.35) IGF1RCYP3A4SYKTNK2
SCHEMBL5085066 0.76 IGF1R (0.44) IGF1RCYP3A4INSREGFRKDR
SCHEMBL4070971 0.74 IGF1R (0.45) IGF1RCYP3A4INSREGFRKDR
SCHEMBL401092 0.74 IGF1R (0.85) IGF1RCYP3A4INSREGFRKDR
SCHEMBL5076858 0.74 IGF1R (0.58) IGF1RCYP3A4INSRTNK2
SCHEMBL5076854 0.74 IGF1R (0.58) IGF1RCYP3A4INSRTNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008076143-A1 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2008-06-26 WO disclosed